106 results about "Rosewood oil" patented technology

The invention belongs to health care products and particularly relates to compound essential oil capable of protecting and developing hairs and a preparation method thereof. The preparation method comprises steps of placing rosewood oil, ylang oil, rosemary oil, ginger oil, cinnamon oil and curcuma oil in a container; stirring to enable all raw materials to be fully mixed evenly; then adding jojoba oil; stirring; fully diluting and fusing; splitting charging and sealing; and achieving the compound essential oil. The compound essential oil uses various plant essential oil for matching scientifically, can well play effects of the plant essential oil due to the synergistic effect, has significant nutrition required for growth of hairs, can quickly activate hair follicles to fast resolve subcutaneous fat and dredge capillaries of scalps to enable active ingredients to quickly reach the hair follicles to achieve the purposes of protecting hairs, raising hairs, preventing alopecia and the like, and is suitable for various hairs and scalps with various characteristics, free of anaphylactic reactions and side effect after being used, quick in effect and good in effects of hair developmentand hair care.

The invention discloses a Chinese medicinal composition for treating cardiovascular diseases, which is prepared mainly from root of red rooted saliva, haw thorn, Chinese angelica root, motherwort, astragalus root, ginseng or Codonopsis pilosula, any one of the compositions may also comprise baras camphor, rosewood oil, liquidambar orientalis mill, musk or musk ketone. The invention also discloses preparations using any one of the medicinal compositions as the effective constituents, preferably drop pills. The auxiliary materials of the drop pill substrate can be polyethylene glycol or natural materials, especially those of plant sources. The medicament has quick effect and good therapeutic action for coronary disease and angina pectoris.

The invention discloses a Chinese medicinal composition for treating cardiovascular diseases, which is prepared from root of red rooted saliva, notoginseng, safflower, Chinese angelica root, motherwort, astragalus root, ginseng or Codonopsis pilosula, any one of the compositions may also comprise baras camphor, rosewood oil, liquidambar orientalis mill, musk or musk ketone. The invention also discloses preparations using any one of the medicinal compositions as the effective constituents, preferably drop pills. The auxiliary materials of the drop pill substrate can be polyethylene glycol or natural materials, especially those of plant sources. The medicament has quick effect and good therapeutic action for coronary disease and angina pectoris.

The invention discloses a Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, which comprises 5.0-80.0% of danshensu extract containing danshensu 50-98%, 15.0-93.0% of pseudo-ginseng extract containing total notoginsen triterpenes 70-98%, and natural borneol or rosewood oil 2.0-15.0%. The composition has evident functions in resisting cerebral ischemia and myocardial ischemia, the curative effect is better than the application of single extract of red sage root or notoginseng, thus providing a more effective and more convenient Chinese medicinal composition and preparation clinically.

The invention discloses a Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, which comprises 2.5-12.0% of tanshinone extract containing tanshinone 55-85%, 57.0-90.0% of total savianolic acid extract containing total savianolic acid 70-98%, 2.5-25.0% of panaxtriol saponins extract containing panaxtriol saponins 80-98%, and natural borneol or rosewood oil 2.5-15.0%. The composition has evident functions in resisting cerebral ischemia and myocardial ischemia, the curative effect is better than the application of single extract of tanshinone, total savianolic acid extract or panaxtriol saponins extract, thus providing a more effective and more convenient Chinese medicinal composition and preparation clinically.

The invention discloses a Chinese medicinal composition for treating cardiovascular diseases, which is prepared mainly from root of red rooted saliva, notoginseng, fleece-flower root, Chinese angelica root, motherwort, astragalus root, ginseng or Codonopsis pilosula, any one of the compositions may also comprise baras camphor, rosewood oil, liquidambar orientalis mill, musk or musk ketone. The invention also discloses preparations using any one of the medicinal compositions as the effective constituents, preferably drop pills. The auxiliary materials of the drop pill substrate can be polyethylene glycol or natural materials, especially those of plant sources.

The invention discloses a Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, which is prepared from red sage root extract 60.0-95.0%, pseudo-ginseng extract 2.5-25.0%, and natural borneol or rosewood oil 2.5-15.0%. The content of danshensu in the salvia miltiorrhizae extract is 3-10%, the content of total savianolic acid is 50-75%, the content of salvianolic acid B is 20-45%, the content of total saponins in pseudo-ginseng extract is 70-98%. The composition has evident functions in resisting cerebral ischemia and myocardial ischemia, the curative effect is better than the application of single extract of red sage root or notoginseng, thus providing a more effective and more convenient Chinese medicinal composition and preparation clinically.

The invention discloses a Chinese medicinal composition for treating cardiovascular diseases, which is prepared from root of red rooted saliva, notoginseng, kudzuvine root, , Chinese angelica root, motherwort, astragalus root, ginseng or Codonopsis pilosula. One of the compositions may also comprise baras camphor, rosewood oil, liquidambar orientalis mill, musk or musk ketone. The invention also discloses preparations using any one of the medicinal compositions as the effective constituents, preferably drop pills. The auxiliary materials of the drop pill substrate can be polyethylene glycol or natural materials, especially those of plant sources. The medicament has quick effect and good therapeutic action for coronary disease and angina pectoris.

The invention discloses a Chinese medicinal composition for treating cardiovascular diseases, which is prepared from root of red rooted saliva, notoginseng, acanthopanax root, Chinese angelica root, motherwort, astragalus root, ginseng or Codonopsis pilosula, any one of the compositions may also comprise baras camphor, rosewood oil, liquidambar orientalis mill, musk or musk ketone. The invention also discloses preparations using any one of the medicinal compositions as the effective constituents, preferably drop pills. The auxiliary materials of the drop pill substrate can be polyethylene glycol or natural materials, especially those of plant sources. The medicament has quick effect and good therapeutic action for coronary disease and angina pectoris.

The invention discloses a Chinese medicinal composition for treating cardiovascular diseases, which is prepared from root of red rooted saliva, notoginseng, Chinese sumac, Chinese angelica root, motherwort, astragalus root, ginseng or Codonopsis pilosula, any one of the compositions may also comprise baras camphor, rosewood oil, liquidambar orientalis mill, musk or musk ketone. The invention also discloses preparations using any one of the medicinal compositions as the effective constituents, preferably drop pills. The auxiliary materials of the drop pill substrate can be polyethylene glycol or natural materials, especially those of plant sources. The medicament has quick effect and good therapeutic action for coronary disease and angina pectoris.

The invention discloses a Chinese medicinal composition for treating cardiovascular diseases, which is prepared mainly from root of red rooted saliva, notoginseng, dragon's blood resin, Chinese angelica root, motherwort, astragalus root, ginseng or Codonopsis pilosula, any one of the compositions may also comprise baras camphor, rosewood oil, liquidambar orientalis mill, musk or musk ketone. The invention also discloses preparations using any one of the medicinal compositions as the effective constituents, preferably drop pills. The auxiliary materials of the drop pill substrate can be polyethylene glycol or natural materials, especially those of plant sources. The medicament has quick effect and good therapeutic action for coronary disease and angina pectoris.

The invention discloses a Chinese medicinal composition for treating cardiovascular diseases, which is prepared mainly from root of red rooted saliva, notoginseng, bitter orange, Chinese angelica root, motherwort, astragalus root, ginseng or Codonopsis pilosula, any one of the compositions may also comprise baras camphor, rosewood oil, liquidambar orientalis mill, musk or musk ketone. The invention also discloses preparations using any one of the medicinal compositions as the effective constituents, preferably drop pills. The auxiliary materials of the drop pill substrate can be polyethylene glycol or natural materials, especially those of plant sources. The medicament has quick effect and good therapeutic action for coronary disease and angina pectoris.

The invention discloses a Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, which comprises 35.0-75% of astragalus root saponin extract containing total saponins 70-98%, 0.5-5.0% of tanshinone extract containing tanshinone 55-85%, 15.0-55.0% of total savianolic acid extract containing total savianolic acid 70-98%, 2.5-15.0% of pseudo-ginseng leaf glycosides extract containing total saponins 80-90%, and natural borneol or rosewood oil 2.5-15.0%. The composition has evident functions in resisting cerebral ischemia and myocardial ischemia, the curative effect is better than the application of single extract of tanshinone, total savianolic acid or pseudo-ginseng leaf glycosides, thus providing a more effective and more convenient Chinese medicinal composition and preparation clinically.

The invention discloses a Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, which comprises 35.0-75% of astragalus root saponin extract containing total saponins 70-98%, 0.5-5.0% of tanshinone extract containing tanshinone 55-85%, 15.0-55.0% of total savianolic acid extract containing total savianolic acid 70-98%, 2.5-15.0% of pseudo-ginseng leaf glycosides extract containing total saponins 70-98%, and natural borneol or rosewood oil 2.5-15.0%. The composition has evident functions in resisting cerebral ischemia and myocardial ischemia, the curative effect is better than the application of single extract of tanshinone, total savianolic acid or pseudo-ginseng leaf glycosides, thus providing a more effective and more convenient Chinese medicinal composition and preparation clinically.

The invention discloses a Chinese medicinal composition for treating cardiovascular diseases, which is prepared mainly from notoginseng, haw thorn, Chinese angelica root, motherwort, astragalus root, ginseng or Codonopsis pilosula, any one of the compositions may also comprise baras camphor, rosewood oil, liquidambar orientalis mill, musk or musk ketone. The invention also discloses preparations using any one of the medicinal compositions as the effective constituents, preferably drop pills. The auxiliary materials of the drop pill substrate can be polyethylene glycol or natural materials, especially those of plant sources. The medicament has quick effect and good therapeutic action for coronary disease and angina pectoris.

The invention discloses a Chinese medicinal composition for treating cardiovascular diseases, which is prepared from root of red rooted saliva, safflower, astragalus root and dalbergia wood oil as the raw material, and the preparation process comprises the steps of mixing red-rooted salvia, safflower and astragalus root to obtain water extract or alcohol extract, subjecting the extract to preliminary settlement treatment, further subjecting the extract to ultrafiltration treatment, concentrating the ultrafiltrate to obtain concrete, mixing with rosewood oil. The invention also discloses preparations using any one of the medicinal compositions as the effective constituents, preferably drop pills.

The invention discloses an anti-depression compound essential oil and applications thereof, wherein the anti-depression compound essential oil comprises, by weight, 15-80% of pure breed cinnamomum camphora leaf oil, 0-10% of michelia leaf oil, 0-30% of michelia alba dc oil, 0-20% of ochrosia coccinea oil, 0-20% of rose oil, 0-10% of laurus nobilis leaf oil, 0-10% of osmanthus fragrans oil, 0-30% of lavender oil, 20-50% of benzoin oil, 0-40% of neroli oil, 0-30% of cedar wood oil, 0-20% of folium artemisiae argyi oil, 0-20% of chrysanthemum oil, 0-20% of litsea cubeba oil, 0-20% of axillary balm herb oil, 0-20% of lemongrass oil, 0-40% of sandalwood oil, 0-20% of sweet orange oil, 0-20% of patchouli oil, 0-20% of vetivert oil, 0-20% of dai-dai leaf oil, 0-20% of dai-dai flower oil, 0-20% of peppermint oil, 0-20% of sage oil, 0-20% of zanthoxylum oil, 0-20% of cananga oil, 0-20% of spikenard extract, 0-20% of clary sage oil, and 0-20% of grapefruit neroli oil. The anti-depression compound essential oil of the present invention can achieve effects of symptom alleviating, pain reducing, and gradual health recovery.

The invention discloses a Chinese medicinal composition for treating cardiovascular diseases, which is prepared mainly from raw material herbs of pseudo-ginseng, Chinese sumac, Chinese angelica root, motherwort, astragalus root, ginseng or Codonopsis pilosula, any one of the compositions may also comprise baras camphor, rosewood oil, liquidambar orientalis mill, musk or musk ketone. The invention also discloses preparations using any one of the medicinal compositions as the effective constituents, preferably drop pills. The auxiliary materials of the drop pill substrate can be polyethylene glycol or natural materials, especially those of plant sources.

The invention discloses a method for preparing Guangxindanshen Dripping Pill, which comprises the steps of: (1) extracting Salvia miltiorrhiza with 75-95% ethanol, filtering to obtain a filtrate, and recovering ethanol from the filtrate under reduced pressure; (2) extracting Salvia miltiorrhiza residue with water or 30-70% ethanol, filtering to obtain a filtrate, concentrating the filtrate, standing, centrifuging, collecting supernatant, and adsorbing with a resin column; (3) rinsing with water, eluting with 30-70% ethanol, collecting eluate, and recovering ethanol under reduced pressure; (4) extracting Panax notoginseng with 30-70% ethanol to obtain an extractive solution, filtering the extractive solution, concentrating, standing, filtering to obtain a filtrate, and adsorbing with a resin column; and rinsing with water, eluting with 30-70% ethanol, collecting eluate, and recovering ethanol under reduced pressure; (5) mixing the above medicinal solutions, and concentrating to obtain a concentrated extract; and (6) mixing the concentrated extract with a matrix material, stirring, adding rosewood oil, mixing, sealing, keeping temperature, and making into dripping pill. The inventive dripping pill has remarkable improvements in terms of contents of effective ingredients, bioavailability, etc.

The invention discloses a special bacterial inhibition type stain remover for leather. The special bacterial inhibition type stain remover is prepared from the following raw materials in parts by weight: 7-12 parts of birch tar oil, 4-7 parts of rosewood oil, 3-5 parts of iso-octyl acetate, 7-12 parts of sodium lauraminopropionate, 5-6 parts of modified polyurethane emulsion, 4-8 parts of isocyanate, 10-18 parts of ethyl acrylate, 6-11 parts of acrylic acid, 10-15 parts of isopropyl alcohol, 5-8 parts of N-alkyl stearamide, 6-12 parts of montan wax emulsion, 5-9 parts of amino silicon oil, 3-7 parts of ethyl acetate, 5-7 parts of dicyclohexyl methane diisocyanate, and 4-8 parts of palm wax. The special bacterial inhibition type stain remover has the beneficial effects that: the special bacterial inhibition type stain remover for leather has good stain removing property and bacterial inhibition, so that the leather is soft and natural in gloss, and ageing oxidization of the leather can be delayed.

The invention discloses a salvia miltiorrhizae preparation for treating coronary disease, which is prepared from the following raw material (by weight ratio), salvia miltiorrhizae 440-520g, notoginseng 440-520g, rosewood oil 3.8-4.6ml.

The invention relates to the technical field of fine chemicals and particularly relates to scar removal repairing face cream and a preparation method thereof. The scar removal repairing face cream comprises, by weight, 0-5% of fructus cinnamoii oil, 0-5% of cranberry oil, 0-5% of aloe oil, 0-5% of shea butter oil, 0-5% of mango butter, 0-5% of Marula oil, 0-5% of sandalwood essential oil, 0-5% ofrose oil, 0-5% of Neal's Yard Remedies oil, 0-5% of rosewood oil, 0-5% of frankincense oil, 0-5% of myrrh oil, 0-5% of pelargonium hortorum oil, 0-5% of tea tree oil, 0-5% of cedar oil, 0-5% of peachwood oil, 0-5% of Helichrysum Italicum oil, 0-5% of vanilla oil, 0-3% of chamomile pure dew, 0-3% of seaweed active extract, 0-3% of Veronicastrum sibiricum extract, 0-3% of calendula officinalis extract, 0-3% of houttuynia cordata extract, 0-3% of centella asiatica extract, 0-3% of acanthopanax root bark extract, 0.5-10% of a penetration enhancer, 3-15% of an emulsifier, 3-10% of a moisturizer and the balance of water. Through use of a variety of natural plant essence ingredients, the scar removal repairing face cream can permeate skin, promote metabolism and promote skin healing and epidermal skin cell regeneration.

The invention discloses a medicament for treating cardiovascular and cerebrovascular diseases, which comprises astragalus root saponin extract 35.0-75%, red sage root extract 15.0-55.0%, panaxtriol saponins extract 2.5-15.0%, and natural borneol or rosewood oil 2.5-15.0%. The content of danshensu in the salvia miltiorrhizae extract is 3-10%, the content of total savianolic acid is 50-75%, the content of salvianolic acid B is 20-45%, the content of total saponins in panaxtriol saponins extract is 80-90%, the content of total saponins in astragalus root saponin extract is 70-98%, the content of Astragaloside IV is 5-15%. The composition has evident functions in resisting cerebral ischemia and myocardial ischemia, the curative effect is better than the application of single extract of red sage root or panaxtriol saponins, thus providing a more effective and more convenient Chinese medicinal composition and preparation clinically.

The invention discloses a Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, which comprises astragalus root saponin extract 35.0-75%, red sage root extract 15.0-55.0%, pseudo-ginseng saponin extract 2.5-15.0%, and natural borneol or rosewood oil 2.5-15.0%. The content of danshensu in the salvia miltiorrhizae extract is 3-10%, the content of total savianolic acid is 50-75%, the content of salvianolic acid B is 20-45%, the content of total saponins in pseudo-ginseng saponin extract is 70-98%, the content of total saponins in astragalus root saponin extract is 70-98%, the content of Astragaloside IV is 5-15%. The composition has evident functions in resisting cerebral ischemia and myocardial ischemia, the curative effect is better than the application of single extract of red sage root or notoginseng saponin, thus providing a more effective and more convenient Chinese medicinal composition and preparation clinically.

The invention discloses a Chinese medicinal composition for treating cardiovascular diseases, which is prepared from root of red rooted saliva, notoginseng, epimedium, Chinese angelica root, motherwort, astragalus root, ginseng or Codonopsis pilosula, any one of the compositions may also comprise baras camphor, rosewood oil, liquidambar orientalis mill, musk or musk ketone. The invention also discloses preparations using any one of the medicinal compositions as the effective constituents, preferably drop pills. The auxiliary materials of the drop pill substrate can be polyethylene glycol or natural materials, especially those of plant sources. The medicament has quick effect and good therapeutic action for coronary disease and angina pectoris.

The invention discloses a Chinese medicinal composition for treating cardiovascular diseases, which is prepared mainly from root of red rooted saliva, notoginseng, red peony root, Chinese angelica root, motherwort, astragalus root, ginseng or Codonopsis pilosula, any one of the compositions may also comprise baras camphor, rosewood oil, liquidambar orientalis mill, musk or musk ketone. The invention also discloses preparations using any one of the medicinal compositions as the effective constituents, preferably drop pills. The auxiliary materials of the drop pill substrate can be polyethylene glycol or natural materials, especially those of plant sources. The medicament has quick effect and good therapeutic action for coronary disease and angina pectoris.

The invention discloses a Chinese medicinal composition for treating coronary disease, which is prepared from raw material herbs of root of red rooted saliva, notoginseng, rosewood oil and safflower or salvia miltiorrhizae, notoginseng, liquidambar orientalis mill and safflower, and the preparation process comprises the steps of mixing red-rooted salvia, notoginseng, safflower to obtain water extract or alcohol extract, subjecting the extract to preliminary settlement treatment, further subjecting the extract to ultrafiltration treatment, concentrating the ultrafiltrate, charging rosewood oil or liquidambar orientalis mill, and producing preparation through the conventional process.

The invention discloses a Chinese medicinal composition for treating cardiovascular diseases, which is prepared from root of red rooted saliva, notoginseng, Breviscapine, Chinese angelica root, motherwort, astragalus root, ginseng or Codonopsis pilosula, any one of the compositions may also comprise baras camphor, rosewood oil, liquidambar orientalis mill, musk or musk ketone. The invention also discloses preparations using any one of the medicinal compositions as the effective constituents, preferably drop pills. The auxiliary materials of the drop pill substrate can be polyethylene glycol or natural materials, especially those of plant sources. The medicament has quick effect and good therapeutic action for coronary disease and angina pectoris.

The invention discloses a Chinese medicinal composition for treating cardiovascular diseases, which is prepared mainly from root of red rooted saliva, notoginseng, trifoliate orange, Chinese angelica root, motherwort, astragalus root, ginseng or Codonopsis pilosula, any one of the compositions may also comprise baras camphor, rosewood oil, liquidambar orientalis mill, musk or musk ketone. The invention also discloses preparations using any one of the medicinal compositions as the effective constituents, preferably drop pills. The auxiliary materials of the drop pill substrate can be polyethylene glycol or natural materials, especially those of plant sources. The medicament has quick effect and good therapeutic action for coronary disease and angina pectoris.

The invention discloses a Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, which comprises 35.0-75% of astragalus root saponin extract containing total saponins 70-98%, 0.5-5.0% of tanshinone extract containing tanshinone 55-85%, 15.0-55.0% of total savianolic acid extract containing total savianolic acid 70-98%, 2.5-15.0% of pseudo-ginseng saponin extract containing total saponins 70-98%, and natural borneol or rosewood oil 2.5-15.0%. The composition has evident functions in resisting cerebral ischemia and myocardial ischemia, the curative effect is better than the application of single extract of tanshinone, total savianolic acid or pseudo-ginseng leaf glycosides, thus providing a more effective and more convenient Chinese medicinal composition and preparation clinically.